Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 12 clinical trials
Study of Elunate (Fruquintinib) in Chinese Patients With Advanced CRC

A phase IV study to characterize safety of Elunate (Fruquintinib) in Chinese patients

  • 3 views
  • 25 Jan, 2021
  • 1 location
A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)

Fruquintinib once daily in 4 weeks treatment cycle (three weeks on and one week off) in combination with Paclitaxel 80mg/day1, 8, 15 of 4 weeks cycle) was well tolerated and demonstrated

  • 12 views
  • 11 Feb, 2021
  • 7 locations
Safety and Efficacy of Genolimzumab (GB226) in Combination With Fruquintinib

This study is a multi-center, open-label, dose-finding phase Ib clinical study with extension phase, which is aimed at evaluating the efficacy and safety of GB226 combined with fruquintinib in

alopecia
platelet count
growth factor
prothrombin
systemic chemotherapy
  • 0 views
  • 13 Mar, 2021
  • 1 location
Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer

This study is a multicenter, dose-escalating phase Ib clinical study to evaluate the safety and tolerability of GB226 in combination with fruquintinib in the treatment of mCRC, evaluate the

fluorouracil
systemic chemotherapy
neutrophil count
major surgery
liver metastasis
  • 2 views
  • 18 Feb, 2021
  • 1 location
Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors

This is an open label, multicenter, Phase 2 study designed to assess the efficacy and safety of tislelizumab in combination with fruquintinib in participants with advanced or metastatic

  • 0 views
  • 14 May, 2021
  • 9 locations
A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy

This is a single center, open-labeled, single arm phase II study aimed to investigate the efficacy and safety of fruquintinib combined with capecitabine as first-line treatment for advanced

  • 0 views
  • 05 May, 2021
  • 1 location
A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Patients With Metastatic Colorectal Cancer

This is a global, randomized, double-blind, placebo-controlled, multicenter phase 3 clinical trial to compare the efficacy and safety of fruquintinib plus best supportive care (BSC) versus

irinotecan
biological therapy
cancer
adenocarcinoma
microsatellite instability high
  • 0 views
  • 30 Apr, 2021
  • 139 locations
Phase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer Patients

criteria took fruquintinib plus Sintilimab until disease progression, death, unacceptable toxicity, withdrawal of consent by the patient, or decision by the treating physician that discontinuation would be

  • 0 views
  • 28 Jan, 2021
  • 1 location
A Multi-Center Open-Label Study of Fruquintinib in Solid Tumors Colorectal and Breast Cancer

An open-label, dose escalation and expansion clinical trial to evaluate the safety, tolerability, and PK of fruquintinib in patients with advanced solid tumors, metastatic colorectal cancer and

irinotecan
tas-102
breast cancer
HER2
biological therapy
  • 12 views
  • 17 Feb, 2021
  • 10 locations
Fruquintinib in Combination With Sintilimab in Patients With Advanced Solid Tumor

This study is composed of dose escalation stage and dose expansion stage. In dose escalation stage, patients with advanced solid tumor will be enrolled and administrated with Fruquintinib in

ovarian cancer
hysterectomy
metastasis
platelet count
cancer
  • 0 views
  • 26 Jan, 2021
  • 1 location